Acute idiopathic pericarditis: current immunological theories

: Idiopathic recurrent acute pericarditis (IRAP) is a rare disease of suspected immune-mediated pathogenesis. It represents a diagnosis of exclusion. It is necessary to rule out infectious and noninfectious causes of pericardial inflammation, including systemic autoimmune and immune-related disorders, eg, Sjögren’s disease, systemic lupus erythematosus. Since pericarditis may precede diagnosis of these disorders, IRAP diagnosis is often made after a long follow-up. According to the two main pathogenetic theories IRAP may represent an organ-specific autoimmune disease or an autoinflammatory disease (AInfD). The main evidence for autoimmunity in IRAP is provided by the detection of serum antiheart and antiintercalated-disk autoantibodies, and the response to anti-inflammatory or immunosuppressive therapy. The findings of familial forms and of proinflammatory cytokines in the pericardial fluid in IRAP would be in keeping with both organ-specific autoimmune disease and AInfD. In fact, AInfD are genetic disorders characterized by primary dysfunction of the innate immune system, due to mutations of genes involved in the regulation of the inflammatory response, in the absence of antigen specific T cells or autoantibodies. In AInfD there are active disease phases with raised non-cardiac specific inflammatory markers, such as C-reactive protein, as well as symptom-free intervals with possible C-reactive protein normalization. A minority of IRAP patients (6%) carry a mutation in the TNFRSF1A gene, encoding the receptor for tumor necrosis factor-alfa. This suggests that some IRAP patients may have an atypical or subclinical form of AInfD. Thus, IRAP may represent a syndrome with distinct pathogenetic mechanisms in different patients’ subsets.

[1]  G. Paolazzi,et al.  Clues to detect tumor necrosis factor receptor-associated periodic syndrome (TRAPS) among patients with idiopathic recurrent acute pericarditis: results of a multicentre study , 2012, Clinical Research in Cardiology.

[2]  M. Galeazzi,et al.  Autoinflammatory diseases and cardiovascular manifestations , 2011, Annals of medicine.

[3]  F. Cinetto,et al.  Azathioprine in isolated recurrent pericarditis: a single centre experience. , 2011, International journal of cardiology.

[4]  A. Brucato,et al.  Prevalence of C-Reactive Protein Elevation and Time Course of Normalization in Acute Pericarditis: Implications for the Diagnosis, Therapy, and Prognosis of Pericarditis , 2011, Circulation.

[5]  M. Senni,et al.  Images in cardiovascular medicine. Bacterial pericarditis due to Providencia stuartii: an atypical case of relapsing pericarditis. , 2010, Circulation.

[6]  C. Baldari,et al.  Familial clustering of recurrent pericarditis may disclose tumour necrosis factor receptor-associated periodic syndrome. , 2010, Clinical and experimental rheumatology.

[7]  A. Angelini,et al.  Anti-heart and anti-intercalated disk autoantibodies: evidence for autoimmunity in idiopathic recurrent acute pericarditis , 2010, Heart.

[8]  Y. Adler,et al.  Antinuclear antibodies in recurrent idiopathic pericarditis: prevalence and clinical significance. , 2009, International journal of cardiology.

[9]  Y. Adler,et al.  Individualized therapy for pericarditis , 2009, Expert review of cardiovascular therapy.

[10]  D. Rigante Autoinflammatory syndromes behind the scenes of recurrent fevers in children. , 2009, Medical science monitor : international medical journal of experimental and clinical research.

[11]  E. Oztekin,et al.  Recurrent pericarditis as the initial manifestation of Familial Mediterranean fever. , 2008, Medical science monitor : international medical journal of experimental and clinical research.

[12]  G. Brambilla,et al.  Corticosteroids for Recurrent Pericarditis: High Versus Low Doses: A Nonrandomized Observation , 2008, Circulation.

[13]  L. Coda,et al.  Indicators of Poor Prognosis of Acute Pericarditis , 2007, Circulation.

[14]  P. Elliott,et al.  Prospective Familial Assessment in Dilated Cardiomyopathy: Cardiac Autoantibodies Predict Disease Development in Asymptomatic Relatives , 2006, Circulation.

[15]  Y. Adler,et al.  Long-term outcomes in difficult-to-treat patients with recurrent pericarditis. , 2006, The American journal of cardiology.

[16]  R. Shabetai Recurrent pericarditis: recent advances and remaining questions. , 2005, Circulation.

[17]  M. Imazio,et al.  Colchicine in Addition to Conventional Therapy for Acute Pericarditis: Results of the COlchicine for acute PEricarditis (COPE) Trial , 2005, Circulation.

[18]  M. Imazio,et al.  Colchicine as first-choice therapy for recurrent pericarditis: results of the CORE (COlchicine for REcurrent pericarditis) trial. , 2005, Archives of internal medicine.

[19]  Y. Shoenfeld,et al.  Idiopathic recurrent acute pericarditis: familial Mediterranean fever mutations and disease evolution in a large cohort of Caucasian patients , 2005, Lupus.

[20]  G. Brambilla,et al.  Recurrent idiopathic pericarditis: familial occurrence. , 2005, International journal of cardiology.

[21]  J. Soler‐Soler,et al.  Relapsing pericarditis , 2004, Heart.

[22]  Raimund Erbel,et al.  Guidelines on the diagnosis and management of pericardial diseases executive summary; The Task force on the diagnosis and management of pericardial diseases of the European society of cardiology. , 2004, European heart journal.

[23]  M. Imazio,et al.  Cardiac troponin I in acute pericarditis. , 2003, Journal of the American College of Cardiology.

[24]  D. Spodick Acute pericarditis: current concepts and practice. , 2003, JAMA.

[25]  J. Piette,et al.  The enlarging clinical, genetic, and population spectrum of tumor necrosis factor receptor-associated periodic syndrome. , 2002, Arthritis and rheumatism.

[26]  B. Maisch,et al.  Cytokine Activation in Pericardial Fluids in Different Forms of Pericarditis , 2000, Herz.

[27]  B. Hoit Diagnosis and Management of Pericardial Disease , 2000 .

[28]  Ian Todd,et al.  Germline Mutations in the Extracellular Domains of the 55 kDa TNF Receptor, TNFR1, Define a Family of Dominantly Inherited Autoinflammatory Syndromes , 1999, Cell.

[29]  R. Powell,et al.  Clinical spectrum of familial Hibernian fever: a 14-year follow-up study of the index case and extended family. , 1997, Mayo Clinic proceedings.

[30]  F. Collins,et al.  Ancient Missense Mutations in a New Member of the RoRet Gene Family Are Likely to Cause Familial Mediterranean Fever , 1997, Cell.

[31]  B Maisch,et al.  Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. , 1996, Circulation.

[32]  C. Agostini,et al.  Immunosuppressive therapy prevents recurrent pericarditis. , 1995, Journal of the American College of Cardiology.

[33]  L. Mestroni,et al.  Evidence from family studies for autoimmunity in dilated cardiomyopathy , 1994, The Lancet.

[34]  M. Yacoub,et al.  Frequency and specificity of antiheart antibodies in patients with dilated cardiomyopathy detected using SDS-PAGE and western blotting. , 1993, Journal of the American College of Cardiology.

[35]  C Bona,et al.  Defining criteria for autoimmune diseases (Witebsky's postulates revisited) , 1993, Immunology today.

[36]  W. Mckenna,et al.  Identification of alpha- and beta-cardiac myosin heavy chain isoforms as major autoantigens in dilated cardiomyopathy. , 1992, Circulation.

[37]  B. Maisch,et al.  Clinical significance of immunopathological findings in patients with post-pericardiotomy syndrome. I. Relevance of antibody pattern. , 1979, Clinical and experimental immunology.

[38]  M. H. Kaplan,et al.  Autoimmunity to the heart in cardiac disease. Current concepts of the relation of autoimmunity to rheumatic fever, postcardiotomyand postinfarction syndromes and cardiomyopathies. , 1969, The American journal of cardiology.

[39]  F. Achilli,et al.  Large pericardial effusion in a family with recurrent pericarditis: A report of probable x-linked transmission. , 2011, Experimental and clinical cardiology.

[40]  M. Cheitlin COlchicine for the Prevention of the Post-pericardiotomy Syndrome (COPPS): a multicentre, randomized, double-blind, placebo-controlled trial , 2011 .

[41]  D. Spodick,et al.  Contemporary Reviews in Cardiovascular Medicine Controversial Issues in the Management of Pericardial Diseases , 2010 .

[42]  A. Martini,et al.  Successful treatment of idiopathic recurrent pericarditis in children with interleukin-1beta receptor antagonist (anakinra): an unrecognized autoinflammatory disease? , 2009, Arthritis and rheumatism.

[43]  Y. Adler,et al.  Therapy for recurrent acute pericarditis: a rheumatological solution? , 2006, Clinical and experimental rheumatology.

[44]  E. Ehler,et al.  Dilated cardiomyopathy: a disease of the intercalated disc? , 2003, Trends in cardiovascular medicine.

[45]  B. Strauer,et al.  Antimyosin autoantibodies are associated with deterioration of systolic and diastolic left ventricular function in patients with chronic myocarditis. , 2000, Journal of the American College of Cardiology.

[46]  P. Angelini The Pericardium: A Comprehensive Textbook , 1997 .

[47]  B. Hesse,et al.  Long-term risk of death, cardiac events and recurrent chest pain in patients with acute chest pain of different origin. , 1996, Cardiology.

[48]  N. Fowler Recurrent pericarditis. , 1990, Cardiology clinics.